Journal
FRONTIERS IN MOLECULAR BIOSCIENCES
Volume 8, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fmolb.2021.682134
Keywords
metabolomics; metabolic profile; NMR spectroscopy; plasma; serum; anticoagulants; epidemiological studies
Categories
Funding
- NIH: NIEHS [P30ES023513, R01ES015359, R01ES031701, R01ES028089, UH3OD023365]
- MIND Institute Intellectual and Developmental Disabilities Research Center [P50HD103526]
- USDA National Institute of Food and Agriculture Hatch Project [1021411]
- Kinsella Endowed Chair in Food, Nutrition, and Health
- [U01CA179582]
Ask authors/readers for more resources
Blood, as a rich biological sample, is routinely collected in clinical and epidemiological studies. Advances in high throughput -omics technology have allowed for deeper exploration of the biological mechanisms involved in disease etiology. However, the impact of the blood collection tube matrix on samples needs to be carefully considered to ensure meaningful biological interpretations.
Blood is a rich biological sample routinely collected in clinical and epidemiological studies. With advancements in high throughput -omics technology, such as metabolomics, epidemiology can now delve more deeply and comprehensively into biological mechanisms involved in the etiology of diseases. However, the impact of the blood collection tube matrix of samples collected needs to be carefully considered to obtain meaningful biological interpretations and understand how the metabolite signatures are affected by different tube types. In the present study, we investigated whether the metabolic profile of blood collected as serum differed from samples collected as ACD plasma, citrate plasma, EDTA plasma, fluoride plasma, or heparin plasma. We identified and quantified 50 metabolites present in all samples utilizing nuclear magnetic resonance (NMR) spectroscopy. The heparin plasma tubes performed the closest to serum, with only three metabolites showing significant differences, followed by EDTA which significantly differed for five metabolites, and fluoride tubes which differed in eleven of the fifty metabolites. Most of these metabolite differences were due to higher levels of amino acids in serum compared to heparin plasma, EDTA plasma, and fluoride plasma. In contrast, metabolite measurements from ACD and citrate plasma differed significantly for approximately half of the metabolites assessed. These metabolite differences in ACD and citrate plasma were largely due to significant interfering peaks from the anticoagulants themselves. Blood is one of the most banked samples and thus mining and comparing samples between studies requires understanding how the metabolite signature is affected by the different media and different tube types.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available